David Miller, senior director, business development, Dicerna Pharmaceuticals [Added: 9:05 pm, 3/28/10]
Doug Miller, director, Amgen
Jackie Millinor, executive coordinator, Cubist Pharmaceuticals [Added: 2:30 pm, 5/21/10]
Cheryl Milroy, human resources manager, RISI [Added: 2:30 pm, 8/15/10]
Tracy (Smith) Mitchell, senior scientist, pharmacology, Adnexus Therapeutics [Added: 3 pm, 5/21/10]
Jack Morgan, Acceleron Pharma
George Morris, director, information technology, Weld Hill Research Center & Arnold Arboretum of Harvard University [Added: 2:10 pm, 3/25/10]
John Morris, associate director, Pfizer [Added: 10:45 am, 3/25/10]
Allan Mufson, chief, cancer immunology and hematology branch, division of cancer biology, National Cancer Institute
Andrea Murphy, senior audit manager, Pfizer [Added: 6:45 pm, 10/22/10]
Kristin Murray, senior manager, global regulatory affairs, Pfizer [Added: 12:30 pm, 3/29/10]
Patricia Murtha-Riel, deceased [Added: 9:35 am, 1/24/11]
Armen Nahabedian, director, global engineering, Pfizer [Added: 7 pm, 4/2/10]
Steve Neben, senior director, project alliance and management, AnaptysBio [Added: 12:45 pm, 12/29/11]
Tammy Neben, research scientist, AnaptysBio [Added: 12:45 pm, 12/29/11]
Justin Neway, chief science officer, Aegis Analytical
Elliott Nickbarg, senior principal scientist,Merck Research Labs [Added: 11:40 am, 6/24/10]
Alexandria Niedzwiecki, legal counsel, Ab Initio Software [Added: 4:55 pm, 10/14/11]
Marie Noel, manager of employee benefits, Vertex Pharmaceuticals [Added: 2:30 pm, 8/15/10]
Marianne Nowacki, associate director of materials management, Shire Human Genetic Therapies
Gina Nugent, senior leader, The Yates Network
Pete Oakes, senior project manager, Pfizer [Added: 1:35 pm, 3/25/10]
Ellie Oberbeck, retired, former secretary to CEO Gabe Schmergel [Updated: 12:30 pm, 9/17/11]
Tom O’Brien, associate director, QA, Pfizer [Added: 2 pm, 4/2/10]
Doug Owen, drug and biologic regulatory affairs consultant
Peri Ozker, acupuncturist and owner, Peri Ozker Acupuncture [Added: 6:20 pm, 3/23/10]
Sharan Pagano, vice president of scientific alliances, Rosa Drug Development Advisors [Updated: 8:45 am, 3/9/11]
Michelle Palmer, director of screening, chemical biology, Broad Institute of MIT and Harvard; president-elect, Society for Biomolecular Sciences
Annamaria Paone, drug supply manager, ArQule [Added: 1:35 pm, 10/4/10]
Gabriela Paredes, consultant, GSP Consulting
Adelene Perkins, CEO, Infinity Pharmaceuticals
Christopher Perley, vice president and general manager of Devens biologics manufacturing facility, Bristol-Myers Squibb
Julie (Manousos) Petros, ABA Special Education Assistant, Town of Andover, MA [Added: 3:40 pm, 5/3/10]
John Pettricciani, biotechnology consultant
Terri Phaneuf, lead investigator IV, APO compliance, Pfizer [Added: 10:15 am, 4/20/10]
Mike Philbrook, director, drug delivery discovery, Genzyme [Added: 5:10 pm, 3/24/10]
Ross Phillips, independent biotechnology professional
Janet Pohlod, district manager-west, Celgene
Steve Potter, associate director, facilities and supply chain operations, Baxter Bioscience [Added: 9:40 am, 1/24/11]
Bill Powers, logistics manager, Alnylam Pharmaceuticals
Carolyn Pratt, executive vice president, RRD International
Mark Ptashne, molecular biologist, Memorial Sloan-Kettering Cancer Center
Praveena Raman, senior information specialist, Elan Pharmaceuticals [Added: 12:50 pm, 3/23/10]
Bernardo Perez-Ramirez, senior scientific director, bioformulations development, Genzyme [Added: 4:30 pm, 3/24/10]
Manish Ranjitkar, quality assurance manager, Vertex Pharmaceuticals
Kathy Reckendorf, senior documentation associate, Millennium: The Takeda Oncology Company [Added: 6:30 pm, 3/31/10]
Christine Resmini, scientist, RXi Pharmaceuticals [Added: 1:40 pm, 10/4/10]
Richard Resnick, CEO, GenomeQuest [Added: 11:10 am, 11/22/11]
Tom Reynolds, senior director of IT, Tolerx
Troy Richards, CMC project manager, Vaccinex [Added: 4:30 pm, 3/24/10]
Rod Riedel, vice president of regulatory affairs, Momenta Pharmaceuticals
Chris Riel, director, quality assurance global compliance operations, Shire HGT [Added: 9:35 am, 1/24/11]
Cheryl Riel, senior manager, nonclinical writing, Millennium: The Takeda Oncology Company [Added: 6:30 pm, 3/31/10]
Ilonna Rimm, senior vice president, director of physician consultation services, Lazard Capital Markets [Added: 2:08 pm, 3/23/10]
John Ripple, CEO, Virdante Pharmaceuticals
Jeff Robinson, head of downstream MSAT, Lonza New England Organization [Added: 2:10 pm, 4/5/10]
Susan Rogers, pharma, IT project management consultant and certified business coach [Added: 10:50 am, 3/24/10]
Eyal Ron, owner, consultant, MADASH [Added: 4:30 pm, 3/24/10]
Vicki Rosen, professor and chair, developmental biology, Harvard University School of Dental Medicine [Added: 6:20 pm, 3/23/10]
Anthony Rotunno, vice president of U.S. Microbial operations, Lonza
David Rozzell, president and CEO, Solidius Biosciences
Kim Rubin, consultant
John Ryan, chief medical officer, Cerulean Pharma
Pat Sacco, vice president of facilities and engineering technical services, acting/interim VP of manufacturing, Shire Human Genetic Therapies [Added: 6:40 pm Eastern, 9/27/10]
Cynthia Sarnoski, retired [Added: 6:40 pm, 7/23/10]
Robert Schaub, senior vice president of discovery and development, Archemix
Neil Schauer, director of DSP research and development, Millipore
Mark Schiavone, tech scientist IV, Pfizer [Added: 2:20 pm, 8/10/10]
Andrea Schievella, business manager, Cancer Research Technology
Jerry Schindler, vice president, biostatistics and research decision sciences, late development statistics, Merck Research Laboratories [Added: 2:20 pm, 3/24/10]
Gabriel Schmergel, board member, PerkinElmer, board member Tufts University Veterinary School
Holly White Schmidt, scientist, discovery protein sciences, Adnexus Therapeutics [Added: 2:30 pm, 5/21/10]
Jay Schrier, senior director, pharmaceutical development, Pacira Pharmaceuticals [Added: 5:30 pm, 3/24/10]
Ullrich Schwertschlag, chief medical officer, Attogen
Steve Scott, director of new product opportunities, GE Healthcare
